ADAM TRIMPE: Open Payments
NPI 1205302460 · LAKE SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 15 payments from 10 companies in 2025. Trend: 2023 $783 · 2024 $806 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $68 |
| ABBVIE INC. | 3 | $52 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: Ozempic, VRAYLAR, Wegovy, FANAPT, INCEPTIV, UBRELVY, MOUNJARO, GEMTESA.
Industry payments across MO — which companies pay providers there.
